"Im Krankenhaus DIAKOVERE Henriettenstift werden jährlich ca. 55.000 Patienten versorgt, davon mehr als 22.000 stationär. Es werden an zwei Standorten in Hannover, Marienstraße und Schwemannstraße Kirchrode, insgesamt 486 Krankenhausbetten vorgehalten. Darüber hinaus stehen am Standort Schwemannstraße weitere 74 Betten zur Geriatrischen Rehabilitation (inklusive 24 tagesklinische Betten), sowie 16 tagesklinische Plätze im Bereich Psychosomatik zur Verfügung. Hier arbeiten mehr als 150 Ärzte und über 500 Pflegekräfte. Das DIAKOVERE Henriettenstift unterhält 14 eigene Kliniken."

During the past decade, Henriettenstiftung Krankenhaus conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Henriettenstiftung Krankenhaus" #1 sponsor was "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 2 trials, followed by "AO Clinical Investigation and Publishing Documentation" with 1 trials sponsored, "ETOP IBCSG Partners Foundation" with 1 trials sponsored, "German Breast Group" with 1 trials sponsored and "Heinrich-Heine University, Duesseldorf" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Henriettenstiftung Krankenhaus" #1 collaborator was "Austrian Breast & Colorectal Cancer Study Group" with 1 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator, "German Breast Group" with 1 trials as a collaborator and "Ossacur Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Henriettenstiftung Krankenhaus" are "Breast Cancer" (4 trials), "Lymphoma" (2 trials), "Alzheimer's Disease" (1 trials) and "High Tibia Osteotomy" (1 trials). Many other conditions were trialed in "Henriettenstiftung Krankenhaus" in a lesser frequency.

Most popular intervention types in "Henriettenstiftung Krankenhaus" are "Drug" (7 trials), "Biological" (3 trials), "Radiation" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (3 trials), "doxorubicin hydrochloride" (3 trials), "filgrastim" (2 trials), "prednisone" (2 trials) and "radiation therapy" (2 trials). Other intervention names were less common.

The vast majority of trials in "Henriettenstiftung Krankenhaus" are 4 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Henriettenstiftung Krankenhaus". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Henriettenstiftung Krankenhaus, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Henriettenstiftung Krankenhaus, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".